Hair Relaxer Lawsuits Heat Up: MDL Judge Rejects Dismissal Motions in May 2025
Are hair relaxer manufacturers finally being held accountable for the harm their products have caused?
The legal battle surrounding hair relaxer products is intensifying, with significant developments unfolding in May 2025. Women across the country are filing lawsuits against major cosmetic companies, alleging that long-term use of chemical hair relaxers led to the development of serious health issues, including uterine cancer, ovarian cancer, and endometrial cancer. The lawsuits claim that manufacturers failed to warn consumers about these potential risks, despite having knowledge of the dangers associated with their products. As of May 1, 2025, over 10,168 cases are pending in the Hair Relaxer Multi-District Litigation (MDL).
MDL Judge Rejects Dismissal Motions
In a significant win for plaintiffs, the MDL judge overseeing the hair relaxer lawsuits has rejected motions to dismiss filed by several defendant companies, including John Paul Mitchell Systems, Wella, and Advanced Beauty. These companies argued that the master complaint lacked specific allegations regarding their products. However, Judge Rowland emphasized that the master and short-form complaints function together, forming a single operative complaint. This ruling allows the lawsuits against these companies to proceed, marking a crucial step forward in holding them accountable for the alleged harm caused by their products.
The Science Linking Hair Relaxers and Cancer
The surge in hair relaxer lawsuits is rooted in growing scientific evidence linking chemical hair straightening products to an increased risk of hormone-related cancers. A key study published by the National Institutes of Health (NIH) in 2022 found that women who frequently used chemical hair straighteners were more than twice as likely to develop uterine cancer compared to non-users. The study, which tracked over 33,000 women for over 11 years, has been cited in nearly every complaint filed in the MDL.
Researchers have pointed to the presence of endocrine-disrupting chemicals (EDCs) in many hair relaxers, such as phthalates and parabens, as a potential cause for the increased cancer risk. These chemicals can interfere with hormone regulation, potentially leading to the development of hormone-sensitive cancers.
Bellwether Trials on the Horizon
As the hair relaxer MDL progresses, the focus is shifting towards bellwether trials, which are early test trials designed to gauge how juries might react to the evidence and testimony presented in similar cases. The outcomes of these trials can significantly influence settlement negotiations and the overall trajectory of the litigation.
The first bellwether trial is scheduled for November 3, 2025, with a second trial set for February 2, 2026. These trials will involve cases where women developed uterine cancer, endometrial cancer, or ovarian cancer after using hair relaxer products. The selection process for these bellwether cases is underway, with both plaintiffs and defendants submitting their lists of potential trial candidates.
What This Means for Potential Plaintiffs
If you have used chemical hair relaxer products and have been diagnosed with uterine cancer, ovarian cancer, or endometrial cancer, you may be eligible to file a lawsuit and seek compensation for your injuries. It is important to consult with an experienced attorney who can evaluate your case and advise you on your legal options.
To support a claim, it is helpful to gather the following evidence:
- Medical records confirming your cancer diagnosis
- Documentation showing a history of your hair relaxer use, such as receipts, product packaging, and photos or videos of applications
- A timeline of events, including the dates of product use and diagnosis
The Future of Hair Relaxer Litigation
The hair relaxer lawsuits are expected to continue to move forward, with more women coming forward to file claims and seek justice for the harm they have suffered. The outcomes of the bellwether trials will be closely watched, as they could pave the way for potential settlements and resolutions in the MDL.
Several factors could influence the timeline for settlements:
- The strength of the scientific evidence linking hair relaxers to cancer
- The ability to prove that manufacturers were aware of the risks but failed to warn consumers
- The severity of the plaintiffs’ illnesses
While the legal process can be lengthy and complex, it is crucial for those affected by hair relaxers to stay informed and seek legal guidance. By holding manufacturers accountable for their actions, these lawsuits can help ensure that consumers are protected from dangerous products and that those who have been harmed receive the compensation they deserve.
Have you been affected by hair relaxers? Contact our firm today for a free consultation to discuss your legal options.